BioStem Technologies, Inc. (BSEM) stock
BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)
Close on Nov 20, 2026Market cap $11.34MP/E –Yield –
BioStem Technologies operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
No operating cash flow figures for BioStem Technologies
BioStem Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?